Tcm Case Study Diabetes


I. Lowering Blood Sugar

by Subhuti Dharmananda, Ph.D., Director, Institute for Traditional Medicine, Portland, Oregon

Diabetes is a major health problem worldwide, but particularly in America. It is estimated that about 2.1% of the world's population has diabetes, but the disease is out of control in America. In the U.S., current estimates are that over 6% of the adult population has the disease, 99% of them with the type 2 diabetes mellitus (late onset or non-insulin-dependent: NIDDM). Type 2 diabetes usually appears around the age of 50 or later, though it can occur during teen years in some cases of obesity. The incidence rate becomes quite high among elderly Americans (20% for those over the age of 65) and in groups with genetic or other predispositions including blacks (14%), hispanics (15%), and Native Americans (19%). Furthermore, the overall incidence of diabetes is growing, apparently because of increased rates of obesity.

CDC data on prevalence of diabetes across the United States in 1994 (left) and in 2000 (right). The rise in diabetes rates is striking. In the year 2000, no states had less than 4% of the population with diabetes, and only 10 states had under 5%.

Despite the major medical advances in rapid and easy monitoring of blood sugar and treatment with drugs, diabetes remains a serious problem. Blood sugar regulation that can be attained by standard methods, particularly when patients are not fully compliant with all medical recommendations, is often not adequate to avoid common secondary effects of diabetes, including cardiovascular diseases, degenerative eye conditions, limb numbness and pain, skin ulceration, and kidney failure. Thus, investigating other avenues for aiding the treatment of diabetes and its secondary consequences is an important undertaking.

Although the incidence of diabetes is far lower in China than in the U.S., predictions are that China and the rest of southeast Asia will rapidly become the world's main site of diabetes cases (by the year 2025) due to the combined high population and change in lifestyle as the countries modernize. The disease has been known since ancient times and it has been a subject of considerable laboratory and clinical research in the Orient. So, the methods of Chinese medicine will no doubt play an important role in the coming years in the population of East Asia. Chinese medical treatment of diabetes includes herbal prescriptions, acupuncture, and dietary recommendations. There is not a single established treatment for diabetes, so it is necessary to review the traditional medical ideas about diabetes and the research that has been conducted to date to give guidance in using these medical therapies. This part of the two-part series focuses on treatments to lower blood sugar; part II focuses on treatment of secondary manifestations of diabetes.

Practitioners of Chinese medicine in the U.S. and other Western countries often have more time to spend consulting with their patients than do medical doctors. This extra time gives an opportunity for exploring with the patient the key roles of exercise and dietary control in limiting the impact of diabetes and preventing its development with aging for those who do not currently have the disease. While acupuncture and herbs are an important option for these patients, it is clear from the evidence that exists that as much or more can be accomplished through changes in behavior. It is necessary for practitioners to keep current with information about dietary advice, as some concepts that were common just a few years ago have turned out to be incorrect or misleading, and are replaced by new approaches backed by recent research.


Chinese medicine owes its current stature to the long history of its practice, dating back more than 2,000 years in a form similar to that utilized today. Chinese physicians appear to have had a reasonably good understanding of diabetes since ancient times. In one of the oldest books about Chinese medical theory, the Huangdi Neijing (1), compiled around 100 B.C., the condition known as xiaoke is mentioned. This is translated today as diabetes or diabetic exhaustion. The literal translation of the term is emaciation-thirst, referring to the disease manifestation when it has gone untreated: namely, one loses body weight despite eating normally, and thirst is persistent. According to this ancient text, the syndrome arises from consuming too much fatty, sweet, or rich food. It is said that it typically occurs among wealthy people: "you ask them to refrain from a rich diet, advice which they may resist." The description fits that of non-insulin-dependent diabetes mellitus.

Two of the traditional herbal formulas most frequently used in modern China and Japan for the treatment of diabetes were described in the book Jingui Yaolue (2), which is about miscellaneous diseases, written around 220 A.D. The text described symptoms characteristic of uncontrolled diabetes, including thirst, frequent urination, and loss of body weight. One of the formulas is Rehmannia Eight Formula (Bawei Dihuang Wan; also called Jingui Shenqi Wan), originally indicated for persons who showed weakness, fatigue, and copious urine excreted soon after drinking water; in some cases, this may have been diabetes as we know it today. The other formula is Ginseng and Gypsum Combination (Baihu Jia Renshen Tang); it was indicated originally for severe thirst and fatigue and is considered ideal for diabetes of recent onset.

In 752 A.D., the distinguished physician Wang Tao mentioned that diabetes was indicated by sweet urine and he recommended the consumption of pork pancreas as a treatment, implying that the pancreas was the organ involved in the disease (3). Further, he suggested that the urine of diabetes patients should be tested daily (by tasting for sweetness) to determine the progress of the disease and its treatment.

Liu Wansu (ca. 1120-1200 A.D.) propounded the theory that diseases are usually caused by heat in the body, which should be countered by herbs that had a cold nature (4). One of his published formulas for diabetes, Ophiopogon and Trichosanthes Combination (Mainendong Yinzi), is traditionally described as clearing heat and nourishing yin. It is comprised almost entirely of herbs that have been shown by modern research to lower blood sugar. Another of his formulas, Siler and Platycodon Formula (Fangfeng Tongsheng San), is recommended by many Japanese doctors for treatment of obesity and accompanying type 2 diabetic syndrome (5).

By the latter half of the 20th century, there were about 200 standard prescriptions recorded as suitable for treating diabetes (6). The majority of these may be viewed as combinations that rely primarily on about two dozen anti-diabetic ingredients (see Table, page 4) plus a small number of auxiliary herbs. These other herbs are understood to have complementary properties (assist the function of the main herbs) or are aimed at treating a specific manifestation of the disease. The main traditional prescriptions brought forward include Rehmannia Eight Formula and its simplified version Rehmannia Six Formula; Ginseng and Gypsum Combination, and Ophiopogon and Trichosanthes Combination.

A theory has arisen as to how diabetes progresses (7, 41). The disease begins with a deficiency of yin. This seems contradictory to the appearance of the patient, who often shows obese constitution and low metabolism, signs that would correspond to excess of yin and deficiency of yang. However, the patients with early stage of diabetes actually have a hyperactive metabolism that does not provide useful energy. Hence, the food nutrients are not successfully utilized; hunger persists, sugar pours out in the urine, thirst develops, and there may be easy sweating. This yin deficiency then generates heat that becomes pathological and then parches the yin. The imbalance of yin and yang eventually degrades and inhibits the qi, so that qi and yin deficiency co-exist. At this point, secondary effects, such as blood stasis and damp-heat, manifest, causing many serious symptoms (29). Without proper nourishment of qi and yin, yang eventually becomes impaired, and the patient, now with advanced disease, has a combined deficiency of qi, yin, and yang.


The research on diabetes treatment has been ongoing for several decades, yet remains in the developmental stages due to the complexity of the task at hand. Initial laboratory animal studies of blood-sugar lowering effects of herbs were conducted in China, Korea, and Japan during the period 1927-1952 (6, 13). Several commonly used herbs were shown to lower blood sugar, including yin nourishing rehmannia, scrophularia, ho-shou-wu, and yu-chu; qi tonifying ginseng, atractylodes, and polygonatum (haungjing, which also nourishes yin); and heat clearing herbs, such as phellodendron, coptis, lycium bark, lonicera, and alisma. This hypoglycemic effect occurred when the herbs were used to treat blood sugar increases induced by epinephrine, which acts as a stress hormone.

Since the 1960s, a much invigorated program of diabetes research arose. New laboratory evaluations were made possible by the finding that the toxic chemical alloxan selectively destroys the beta cells of the pancreas. Thus, mice, rabbits, or other laboratory animals treated with this compound suffer from a diabetic syndrome quite similar to that of a person who has insulin-dependent diabetes (type I, early onset). Dr. S. Nagayoshi was able to report that Rehmannia Eight Formula reduced blood sugar in alloxan-treated rabbits in a 1960 journal report (6). Comparing the herbal effects in normal laboratory animals with those in alloxan-treated animals provides some indication of the mechanisms by which the herbs affect blood glucose levels; further information is obtained when using the same herbs to treat animals affected by epinephrine. Progress has been made with studies of a genetic strain of mice-first described in 1979-that gain weight unusually and begin developing a type 2 diabetes after about 10 weeks of growth. These mice were used in a study of the hypoglycemic role of ginseng and its active constituents in the traditional formula Ginseng and Gypsum Combination (24).

Perhaps the most extensive laboratory investigation of Chinese herbs for diabetes has been carried out by Huang Ray-Ling and his coworkers at the National Research Institute of Chinese Medicine in Taiwan (16). Dr. Huang tested a variety of herb extracts in both alloxan-treated mice and normal mice, in order to compare the impacts of the herbs with or without insulin involvement. To obtain more significant results, blood sugar responses were monitored at different times after administration of herbs, in glucose tolerance tests, and with differing dosages of the herb materials.

Herbs that showed significant hypoglycemic action in both alloxan-treated and untreated mice included some that were not commonly used in traditional formulas, such as red atractylodes (cangzhu), cyperus, and phaseolus (mung bean). Herbs that showed a substantial hypoglycemic effect in alloxan-treated mice but little effect in normal mice, however, matched the pattern of traditional herb therapy; they include rehmannia, scrophularia, astragalus, coix, moutan, lycium bark, lycium fruit, trichosanthes root, alisma, and asparagus root. Traditional herb formulas that had significant hypoglycemic activity by these tests included Rehmannia Six Formula (Liuwei Dihuang Tang), Rehmannia Eight Formula (Bawei Dihuang Tang), and Ginseng and Gypsum Combination (Baihu Jia Renshen Tang).

The dosages of herbs administered to the mice to obtain the significant hypoglycemic action ranged from 1.25 to 5.0 grams/kg. These dosages are quite high, and it is difficult to translate the effects seen in these diabetes models with these herb dosages to human requirements, but human dosages would be expected to be at the high end of the range normally recommended for treatment of other diseases based on these figures.

A summary of Chinese laboratory research on hypoglycemic agents, reported in the books Modern Study and Application of Materia Medica (30) and Pharmacology and Applications of Chinese Materia Medica (13) yielded the following listing of herbs. Only the commonly used items are included here; there were also a small number of additional herbs that showed positive effect but are not included repeatedly in prescriptions mentioned in the published clinical trials. Note that most of the materials are roots and rhizomes and many of the herbs contain saponins or their aglycones, triterpenoids.

Common Name
Pinyin Name
Botanical Name
Plant Part
Alisma plantago-aquatica
in Rehmannia Six and Rehmannia Eight Formula; contains triterpenes
Anemarrhena asphodeloides
in Ginseng and Gypsum Combination and Ophiopogon and Trichosanthes Combination; contains saponins that have hypoglycemic action
Astragalus membranaceus
contains flavonoids and saponins
Atractylodes macrocephala
contains essential oils; action of decoction is slow: 2-5 hours
Atractylodes, red
Atractylodes lancea
contains essential oils; gradual decrease in blood sugar for alloxan treated rabbits
Dioscorea batatas
in Rehmannia Six and Rehmannia 8 Formula; contains saponins
Panax ginseng
in Ginseng and Gypsum Combination and Ophiopogon and Trichosanthes Combination; contains saponins
Polygonum multiflorum
treats peripheral neuropathy; contains anthraquinones
Poria cocos
in Rehmannia Six and Rehmannia Eight Formula and in Ophiopogon and Trichosanthes Combination
Lycium bark
Lycium chinense
slow and lasting action in reducing blood sugar
Lycium chinense
produces sustained decrease in blood glucose; increases tolerance to carbohydrates
Platycodon grandifolium
contains saponins; reduces blood glucose in normal and alloxan-treated animals
Polygonatum sibiricum
inhibits epinephrine-induced hyperglycemia
Pueraria lobata
in Ophiopogon and Trichosanthes Combination; contains flavonoids
Rehmannia glutinosa
in Rehmannia Six and Rehmannia 8 Formula and Ophiopogon and Trichosanthes Combination
Salvia miltiorrhiza
shows prolonged hypoglycemic effect; contains quinines
Scrophularia ningpoensis
action is weaker than rehmannia
Trichosanthes kirilowii
in Ophiopogon and Trichosanthes Combination
Polygonatum officinale
contains glycosides; reduces blood sugar in alloxan-treated rats


Clinical trials of Chinese herbs for diabetes have been conducted with increasing frequency over the past thirty years. At the 9th Symposium of Oriental Medicine in 1975, Dr. Takahide Kuwaki reported on partial success in treating 15 diabetes patients with traditional herb formulas; nine of the patients treated (duration of using herbs ranged from 2 to 36 months) showed notable improvements (6). In Beijing, a Diabetes Unit was established in 1975 at the Department of Traditional Chinese Medicine at the Capital Hospital; a summary of their recommendations has been published in America, giving an opportunity for Western practitioners to provide similar treatments to their patients (14). In Changchun, the Kuancheng Institute of Diabetes was established; in 1989 researchers there published results of a highly successful clinical trial of herbs used for treating diabetic ketonuria, in which 28 of 33 patients showed marked improvements after consuming a complex formula comprised almost entirely of herbs that individually have hypoglycemic actions (15). These Chinese clinics, and other facilities in China and Japan, have provided herbal treatments to thousands of patients with diabetes, and the results have often been monitored and reported.

Examples of clinical recommendations and evaluative trials for the treatment of diabetes are presented in the book Modern Clinic Necessities for Traditional Chinese Medicine (17). The formulas that had been shown to have hypoglycemic effects in the animal studies, Rehmannia Six Formula and Ginseng and Gypsum Combination, were recommended to treat those who have normal insulin secretion but suffer from diabetes (this would be type 2, or insulin-independent diabetes). These formulas are for the common qi and yin deficiency syndrome found in early stage of clinical symptoms. A traditional variation of Rehmannia Six Formula was also suggested, made by adding anemarrhena and phellodendron (to form Zhi Bai Dihuang Wan).

Reducing Sugar Tablet A (Jiang Tang Jia Pian), comprised of astragalus, polygonatum, trichosanthes root, pseudostellaria, and rehmannia, was recommended for those with low levels of insulin, but who are still capable of producing insulin. The herbs were administered as extracts in tablet form, with 2.3 grams raw material per tablet, 6 tablets each time, three times daily, for a total dose of over 40 grams per day (raw materials equivalent). The effects were said to be enhancing sugar tolerance and elevating the level of serum insulin. In the treatment of 405 cases of diabetes with this preparation at the Guanganmen Hospital, 76.5% of the patients had improved sugar tolerance. Among those patients who most closely fit the therapeutic pattern of the herbs-those with qi and yin deficiency-the effective rate was slightly higher, 81%.

Rehmannia Eight Formula was recommended for those patients who produced little or no insulin. This is for patients with advanced disease, representing a deficiency of yin and yang (the cinnamon bark and aconite added to Rehmannia Six Formula to produce Rehmannia Eight Formula are said to restore yang). In laboratory animal studies, use of this formula resulted in reduction of water demand (thirst), blood sugar, and sugar spill into the urine.

Jade Spring Pill (Yu Quan Wan), a patent formula from China, is recommended for diabetes treatment in the dosage of 50 grams per day (the original form was large honey pills of about 6 grams each), for at least one month. In laboratory animal studies, this formula was shown to increase glycogen in liver cells. The Sichuan Province United Pharmaceutical Manufactory, developed a second generation of Jade Spring Pills comprised of pueraria, trichosanthes root, rehmannia, licorice, schizandra, and other herbs not mentioned on the label. These pills are indicated in the package labeling for the "ill function of the islets of Langerhans." The relatively small pills are packed into small bottles with a total of 6 grams each, and 20 bottles are packed in one box, accompanied by instructions to take one bottle each time, four times daily (the box is a five day supply at 24 grams/day). Compared to the first generation, it is said on the package insert, the new product had been clinically proved to have an improved rate of cure and that the dose had been reduced. Jade Spring Pill is useful for the early stage of diabetes, when yin deficiency and dryness dominate. In a recent clinical evaluation of a Chinese herb formula for diabetes, Jade Spring Pills, used for the control group, was reported to be effective in reducing blood sugar for 79% of cases treated (33).

Several clinical trials have been reported in Chinese medical journals with brief English summaries appearing in Abstracts of Chinese Medicine (a Hong Kong publication produced from 1986-1996). A representative report is one that originally appeared in the Journal of the Zhejiang Traditional Chinese Medical College in 1989 (18). Patients were treated with a decoction containing astragalus, codonopsis, rehmannia, gypsum, salvia, persica, carthamus, red atractylodes, anemarrhena, and tang-kuei. This combination of qi and yin tonics plus blood vitalizing herbs is appropriate to treating patients with a middle stage disease showing some secondary symptoms. Modifications of the formula would also be made for the specific symptoms. The patients showed a variety of secondary manifestations of the disease, including nephropathy, peripheral neuropathy, dermatological disorders, retinitis, and liver cirrhosis. Among 19 non-insulin dependent cases treated, fasting blood glucose levels decreased from the pretreatment range of 160-300 mg% to 80-110 mg%. One patient with insulin-dependent diabetes showed a decline in fasting blood sugar from 500 mg% before treatment to readings of 110-200 mg% after treatment. Generally, it was found that blood glucose decreased after 1-2 weeks of treatment and became steady after one month, and the blood glucose changes were followed by symptomatic improvements.

A new patent formulation developed by the Chengdu University of Traditional Chinese Medicine and Pharmacology is made comprised of Gui Shao Dihuang Wan (Rehmannia Six Formula with tang-kuei and red peony) with added morus leaf, litchi seed, and coptis. The latter three herbs were recently demonstrated to be effective in lowering blood sugar (34, 35, 36).


Although certain herbs have been identified as having hypoglycemic activity, Chinese physicians prefer using them in a formulation that addresses differential diagnosis rather than relying solely on herbs proven effective in laboratory tests. As an example of how the herbs are used in this context, the following is the strategy outlined by Lu Renhe in the treatment of 865 elderly patients with diabetes (41); the large number of patients allowed highly differentiated diagnostic categories. He first divided the disease into five stages, representing a progression from simple yin deficiency to complete break down of the body systems (note that "impairment" is more severe than deficiency, in that it involves active degradation):

I. Yin deficiency; preclinical stage.
II. Yin deficiency produces internal heat; early clinical manifestation
III. Impairment of both qi and yin; early stage of complications
IV. Impairment of qi, yin, and yang; stage of intermediate complications
V. Failure of qi, yin, and yang; stage of advanced complications

The first four stages were subdivided into a total of 16 syndromes based on the organ systems affected and types of disorders generated by the basic pattern. Within each of these subcategories, the patients could further be grouped according to the severity of manifestation, but this did not influence the choice of herbs to use in treatment. For each pattern, a base formula of 8-12 herbs was presented (see Table below). Among the herbs used in the formulas listed in this table, there is frequent reference to a few that are known as hypoglycemic agents. These are (number of formulas that include each herb in parentheses):

pueraria (12)
rehmannia (8)
trichosanthes (7)
scrophularia (7)
salvia (7)
polygonatum (6)
ho-shou-wu (6)
ophiopogon (6)

Aside from these herbs, some herbs were used with less frequency, but commonly relied upon for certain syndromes:

coptis to clear heat
achyranthes to vitalize blood circulation
hoelen to remove dampness
rhubarb to purge the intestines

In the case of rhubarb-containing formulas, the rhubarb would be included only so long as constipation remains a problem; after that, it could be removed.

Differential Treatment of Diabetes by Stage and Syndrome

Syndrome (# of patients)
Principle of TreatmentMain Herbs
I. Yin deficiency causing hyperactive yang (9) nourish yin, check exuberance of yang rehmannia (raw), ho-shou-wu, ophiopogon, pueraria, trichosanthes, haliotis, mother of pearl, coptis, achyranthes
I. Deficiency of yin with exuberance of liver (11) replenish liver yin rehmannia (raw), scrophularia, ophiopogon, peony, ho-shou-wu, pueraria, trichosanthes, licorice, salvia
II. Retained heat in the stomach and intestines (70) dispel evil heat from the stomach and intestine, protect qi and yin gypsum, calcite, chih-shih, adenophora, yu-chu, rehmannia (raw), pueraria, trichosanthes, coptis, rhubarb
II. Stagnant qi of the liver transforming to heat (65) disperse stagnancy of qi of the liver and remove evil heat bupleurum, peony, red peony, chih-ko, chih-shih, magnolia, pueraria, trichosanthes, coptis, scrophularia, rhubarb
II. Deficiency of spleen with accumulation of dampness and heat (50) invigorate the function of the spleen, resolve dampness, assisted by removal of heat and diuresis red atractylodes, phellodendron, achyranthes, coix, polyporus, hoelen, magnolia, citrus, capillaris, pueraria, trichosanthes
II. Retained heat in the lung forming toxic heat (20) clear heat in the lung, remove toxin adenophora, ophiopogon, scute, morus bark, lonicera, forsythia, scrophularia, ho-shou-wu, pueraria, trichosanthes, chin-chiu
III. Unrelieved dryness and heat leading to impairment of qi and yin of the kidney (80) reinforce the kidney, replenish qi, overcome dryness, invigorate blood circulation polygonatum, rehmannia (raw), ho-shou-wu, scrophularia, pueraria, trichosanthes, salvia, achyranthes
III. Impairment of qi and yin causing lack of nourishment to the channels and conduits (90) reinforce the kidney, replenish qi, invigorate blood circulation, strengthen the pulse to restore flow of qi polygonatum, rehmannia (raw), ho-shou-wu, pueraria, red peony, salvia, dipsacus, chaenomeles, achyranthes, chin-chiu
III. Impairment of qi and yin damaging the spleen and lung (80) reinforce qi, invigorate the spleen, replenish the qi of the lung astragalus, atractylodes, siler, morus bark, adenophora, ophiopogon, scrophularia, persica, apricot seed, pueraria, chih-shih
III. Impairment of qi and yin damaging the heart and spleen (50) reinforce the kidney and replenish qi of spleen and heart polygonatum, pseudostellaria, ophiopogon, schizandra, rehmannia (raw), coix, hoelen, salvia
III. Impairment of qi and yin resulting from persistent dampness (60) regulate the center to resolve dampness, protecting the qi and yin platycodon, atractylodes, magnolia, hoelen, citrus, pinellia, codonopsis, pueraria, coptis, capillaris, scrophularia, rhubarb
III. Impairment of qi and yin causing stagnancy in the liver with blood stasis (65) replenish qi, nourish yin, remove stagnancy of the liver, resolve blood stasis pseudostellaria, polygonatum, scrophularia, rehmannia (raw), bupleurum, peony, chih-ko, salvia, persica, polygonum fruit, schizandra, crataegus
IV. Impairment of yin, yang, and qi leading to stagnation of phlegm and qi (50) regulate and replenish yin and yang and activate the blood polygonatum, tang-kuei, cibotium, dipsacus, chaenomeles, rehmannia (raw), red peony, clematis, gleditsia, centipede, pueraria, trichosanthes
IV. Impairment of yin, yang, and qi causing lack of nourishment for the pectoral energy and sinews (30) reinforce the qi, replenish the kidney, invigorate the yang, strengthen the sinews American ginseng, deer antler gelatin, tortoise shell gelatin, pipefish, seahorse, cardamom, aquilaria
IV. Impairment of yin, yang, and qi causing lack of nourishment to the tendons and muscles (30) reinforce qi, invigorate the spleen, nourish the liver and kidney Astragalus, tang-kuei, pseudostellaria, atractylodes, polyporus, hoelen, salvia, cnidium, lycium, epimeidum, ophiopogon, pueraria, chaenomeles
IV. Impairment of yin, yang, and qi causing lack of nourishment to the stomach and intestines (40) regulate and reinforce qi, move the bowels polygonatum, tang-kuei, scrophulari, ho-shou-wu, peony, licorice, chih-shih, salvia, schizandra, cistanche
V. Failure of yin, yang, and qi (85) attempt emergency treatment address specific manifestations of failure


The dosage of herbs applied to treatment of diabetes is often quite high. As revealed by the experience with Reducing Sugar Tablet A and Jade Spring Pills, a formula that is considered highly effective must be taken in dosages of about 12-24 grams per day even when presented as a highly condensed extract (made from about 40-80 grams of crude herbs) in convenient form. This apparent requirement is reflected in several books that recommend herbs in decoction form.

In the book Clinical Experiences (19), a number of different decoctions are suggested. The dosages of the formulas range from that of an "experiential prescription" containing three herbs (astragalus, rehmannia, and dioscorea, 30 grams each in decoction) at a total dose of 90 grams per day, to a dozen herbs in each of three formulas for yin deficiency syndrome (each prescription contains rehmannia, ophiopogon, and scrophularia), with about 120-150 grams for one day. There is also presented in this book a modified Rehmannia Eight Formula for advanced cases showing yang deficiency, with about 170 gram per day dosage. Added to Rehmannia Eight Formula are the anti-diabetes herbs trichosanthes root, pueraria, salvia, and atractylodes. Regarding efficacy, it is stated that the early-onset type of diabetes responds poorly, but the insulin-independent type with slow onset responds favorably.

In the book 100 Famous and Effective Prescriptions of Ancient and Modern Times (20), the Decoction for Diabetes (Yi Tang Tang) is mentioned. It contains rehmannia, trichosanthes root, dioscorea, gypsum, ophiopogon, dendrobium, and seven other herbs. Taken as a decoction, the standard formula is made with 226 grams of herbs for a daily dose. This formula is usually prescribed with additional herbs to address specific symptoms, so that the total daily dosage often reaches 250 grams. In a study with 215 diabetic patients, it was reported that 62 cases were relieved of thirst, overeating, polyuria, and sugar in the urine; the fasting blood glucose declined to below 130 mg%. Additionally, 88 others had some degree of improvement (total effective rate: 70%).

In the book Integrating Chinese and Western Medicine (21), four herb formulas are described: each of the formulas, a two day supply of herbs, is made with over 250 grams of herb materials (thus, over 125 grams/day). All four formulas contain twelve to thirteen herbs, and they all include pueraria, rehmannia, and salvia. Nothing is said directly about the degree of effectiveness of the formulas, but the text ends with the comment that certain pills "are also very effective," citing Rehmannia Six Formula, Jade Spring Pills, and Diabetes Pills (Xiao Ke Wan).

In A Clinical Guide to Chinese Herbs and Formulas (22), three formulas for diabetes are presented. The formulas are comprised of typical hypoglycemic herbs as mentioned above, and the dosage is usually 10-15 grams of each major ingredient, with 6-7 major ingredients, and a total dosage of about 100 grams per day. The formulas can be modified for specific symptoms, which might add about 10 to 30 grams of herbs.

The large amount of raw materials apparently needed for treating diabetes may be a reflection of the need to consume several hundred milligrams of mixed non-toxic active components (e.g., flavonoids, saponins, alkaloids, iridoids, anthraquinones) derived from herbs to attain substantial physiological improvements within a typical treatment period of three months or less. It is expected that most of the anti-diabetic active constituents are present at a level of approximately 2% (or less) of the dried herb material. Decoctions that have 90-150 grams of materials (or more), might yield only about 2 grams of hypoglycemic constituents, perhaps an average of 250 mg of each chemical type.

Condensing the active components will yield dried materials that must be taken at a level that is often still regarded as inconvenient by many. For example, dried decoctions (manufactured mainly in Taiwan and Japan) of mixed herbs typically yield a product that is about a 5:1 concentration factor (500 grams of raw materials yields 100 grams of finished product). Such materials are available in the West and often packaged in units of 100 grams. To obtain the equivalent of a dosage of 100 grams of crude herbs in decoction, one would consume about 20 grams of the dried extracts (a one day dose), and a bottle of herbs would be a 5 day supply. This is similar to the dosing for the second generation Jade Spring Pills described above, made of condensed extracts.

Attempts have been made to isolate active constituents, as one way of making treatment more convenient, but one then loses several of the purported advantages of whole herbs and formulas. One item of current interest is the alkaloid berberine, which has many therapeutic uses, including treatment of hyperglycemia. Rats treated with alloxan and with berberine were less likely to show blood glucose rise and pathological change in the beta cells. Insulin-independent diabetes patients treated with 300-500 mg of berberine daily for one to three months (along with dietary control), showed definite reduction of blood sugar (23). Berberine is an active component of coptis and phellodendron, used in several diabetes prescriptions.

A flavonoid-rich fraction isolated from guava leaves was extracted, made into tablets with 400 mg of the concentrate in each, and administered at a dosage of 6-12 tablets each time, three times daily (total daily dose is 7.2-14.4 grams), to produce hypoglycemic action (17). Flavonoids are active components of many herbs, though not necessarily the key components of most anti-diabetes herbs.

Ginseng and its saponins have been studied in alloxan-treated, genetically diabetic, and normal mice (24), revealing a hypoglycemic effect; ginseng saponins also stimulate the production of insulin. In elderly patients with hyperglycemia, the saponins reduced serum glucose (25). Ginseng saponins are typically provided in tablets of 50 mg each, with a dose of 1-2 tablets each time, two to three times per day. Other saponins, such as those in platycodon and the Indian herb gymnemma, have been shown to lower blood sugar, and the dosing appears to be in a range of about 300 mg/day or more.

Still, an article in the Journal of Traditional Chinese Medicine (26) suggests that a condensed blend of herbs can be prescribed in moderate dosage. This article described treatment of 102 cases of non-insulin-dependent diabetes, using the Gan Lu Xiao Ke capsule, with rehmannia, codonopsis, astragalus, ophiopogon, asparagus, scrophularia, cornus, tang-kuei, hoelen, alisma, and cuscuta. Patients were treated with the herbs for three months. The group average blood glucose level fell from an initial value of 200 mg% to 154 mg%. The dosage of material in the capsules was only 5.4 grams per day. However, the results were also modest (30% were markedly improved, 57% were improved, but the average blood sugar remained quite high), and patients would receive additional herbs to treat specific symptoms: those herbs, adding to the total dosage, might also contribute to the hypoglycemic action.

Another example, was a report about treatment of persons with vascular complications of insulin-independent diabetes (e.g., coronary heart disease, vascular disease of the lower extremities, stroke, retinopathy, etc.). They were treated with a sugar-reducing, pulse-invigorating formula. Unfortunately, the ingredients were not specified other than astragalus and rehmannia; the formula is said to tonify qi, nourish blood, and vitalize blood. The herbs were simply powdered and given in capsules, at a dosage of 2-3 grams each time, three times daily (29). The treatment time was three months, and if the treatment was deemed effective, it would then be continued. Improvements in blood parameters were noted in 82% of the cases that fit the pattern of qi and yin deficiency (which the formula mainly addressed), but only about 63% for other cases (yin deficiency with fire, or yin and yang deficiency; the more advanced cases). Fasting blood sugar was maintained below 150 mg% for 77% of those treated.

Further investigation is necessary to determine the minimum formula size (number of ingredients) and the proper dosage of those ingredients, as well as the best form (powdered herbs, extracts, or a combination) to get the desired effects. The use of nutritional supplements (9) and Oriental dietetic practices (10) might add to the benefits of herbal medicine prescriptions, a factor that has not yet been the subject of study.


There is no evidence that diabetes drugs and Chinese herb therapies are incompatible, but there is a concern that when combining the two, the blood sugar may decline too far. If the herbs are added gradually over a few days with continued monitoring of blood sugar, this problem can be avoided. When herbs successfully contribute to lowering blood sugar, drug dosage may be reduced under a physician's instructions.

While Chinese literature sometimes mentions, in passing, the use of Chinese herbs along with modern drugs, specific strategies for combining the two are not commonly presented. A report on integrated Chinese and Western treatment of diabetes was published in 1987 (27). For insulin-dependent diabetics, a formula made with codonopsis, astragalus, atractylodes, rehmannia, ophiopogon, and lycium fruit was given (the formula tonifies qi and nourishes yin). For those with non-insulin-dependent type, they were treated with the same mixture either alone or with tolbutamide or glyburide. The herbs, prepared in liquid form, were given twice daily for three months. It was reported that the herbs exhibited a hypoglycemic effect and synergized with insulin and other drugs. For the group of 53 patients treated, the average fasting blood glucose at the beginning was 177 and at the end of the three months was 135. In another clinical trial (18), a group of 10 patients was identified who had responded poorly to Western drugs and also failed to respond to Chinese herbs. They were then given both the herbs and drugs concurrently. Significant improvements were observed in eight of the ten patients. Further, ginseng is reported to reduce the dosage of insulin needed by patients and to prolong the action of a dose of insulin (13).


Acupuncture therapy is a common approach to treating diabetes in China. Many Americans assume that acupuncture is only suitable for treating pain, perhaps because the initial introduction of acupuncture was mainly for this application. Indeed, the general opinion here appears to be that acupuncture ought to be used mainly for treating chronic back pain. Therefore, relatively few people have turned to acupuncture for treating the disease. Increasingly, people with pain and other health problems for which acupuncture is selected also have diabetes.

A report in the 1994 Journal of Traditional Chinese Medicine (37) serves as a model of Chinese research on acupuncture. The researchers recruited 60 patients with diabetes and divided them randomly into two groups: the acupuncture group (38 patients) and the control group (22 patients); the two groups were found to be well matched for symptoms and laboratory results (blood and urine tests). Both groups followed a regulated diet during the study, but one group received acupuncture. Electrical stimulation of the needles was used (this method replaces twirling the needle by hand and provides a pulsating stimulus that can be continued for the entire treatment period). Acupuncture was administered once a day for 30 days. The main acupuncture points used were quchi (LI-11), sanyinjiao (SP-6), zusanli (ST-36), and yishu (special diabetes point located at 1.5 cun lateral to the lower border of the spinous process of the 8th thoracic vertebra). Supplemental points include yuji (LU-10), guanyuan (CV-4), and baihui (GV-20).

For the control group, a well-known herbal pill, Xiaoke Wan or Diabetes Pill, was administered. This pill had been the subject of earlier study and the level of effectiveness was already established. The patients were not using diabetes drugs during the trial except for 8 patients who required insulin injections.

To evaluate the effects of treatment, three levels of responses were defined. Patients who experienced markedly effective results were those who had their initial symptoms essentially disappear by the end of the one month treatment and their fasting blood-sugar levels had dropped below 130 (or the blood sugar two hours after a meal would be below 150). Further, the 24-hour, urine-sugar content was reduced by 30% or more at the end of treatment compared to beginning of treatment. These patients were not "cured" of diabetes but they showed very evident improvements. For those deemed effectively treated (not markedly effective), symptoms were improved but not gone, and fasting blood-sugar levels dropped to below 150 (or two hours after meals below 180), and the 24-hour, urinary-sugar excretion declined by at least 10% from initial values (but not up to 30%). If these standards could not be met, then the treatment was deemed ineffective. All but two of the patients showed declines in blood sugar and urinary sugar excretion and improvements in symptoms. More than one-third of the patients had marked improvement.

For the 38 participants in the acupuncture group, there were 25 cases rated markedly effective and 10 cases rated effective: nearly 2/3 of the patients treated showed marked improvement and only three patients failed to respond. Further, it was reported that the patients receiving acupuncture experienced a statistically significant decline in cholesterol, triglycerides, and beta-lipoproteins. The drop in triglycerides was most substantial, with a decline from an average value of 151 at the start to 117 one month later (a decline of more than 20%). There were significant improvements in "nail-fold microcirculation," which is a measurement of blood circulation through capillary beds (poor circulation through these beds is one reason persons with diabetes suffer from skin ulceration), which has also been observed in other diabetes studies (11, 12). Among those who were using insulin, the amount needed after the 30 days of acupuncture declined in six of the eight individuals; in two of those cases, the insulin could be stopped altogether.

The objective of the study was to show the benefits of acupuncture, using a common patent pill for the control group. Among the 22 participants who took the diabetes pill, there were 8 cases rated as markedly effective and 12 cases as effective (2 ineffective). In both the acupuncture and herb pill groups, most patients responded well. The authors of the study concluded: "the therapeutic effects of acupuncture on diabetes are similar to those of the diabetes pills, however, acupuncture excels in the prevention of complications, especially cardiovascular diseases."

In another study, the acupoint sanyinjiao (SP-6) was used as the primary treatment, with adjunctive points according to syndrome differentiation for 30 patients with diabetes (38). Among the common adjunct points were feishu (BL-13) plus sanjiaoshu (BL-22) for thirst and dryness of the mouth; zusanli (ST-36) for hunger; and taixi (KI-3) plus shenshu (BL-23) for polyuria. Treatment was administered once daily for 12 days as a course of treatment, then a 2-3 day break before starting another course. Needle retention was for 30 minutes following getting the qi sensation. The author noted that the effectiveness of treatment (evaluated as reduction of blood sugar to normal or near normal) was better for younger patients than for older patients and that it generally took 2-3 courses of treatment to get optimal results. He pointed out that diabetes may be due to a combination of deficiency syndrome of qi and yin complexed with blood stasis: "Sanyinjiao is the crossing point of the liver channel, spleen channel, and kidney channel, which has the actions of supplementing qi, nourishing yin, and removing blood stasis. Acupuncture of sanyinjiao can therefore regulate the level of blood sugar in the body."

Differentiation of the disease manifestation with corresponding acupuncture for each syndrome was reported by Liu Zhicheng and Sun Fengmin of the Nanjing College of Traditional Chinese Medicine (39). Their treatment patterns are summarized in the table below:

(Number of Patients)
Principle of TreatmentMain Points
(Body Points)
Dry heat in the lung and stomach (33) clear away heat, moisten and promote production of body fluids feishu (BL-13), weishu (BL-21), neiting (ST-44), zusanli (ST-36)
Dry intestines and impairment of body fluids (13) nourish yin, irrigate the intestines quchi (LI-11), fenglong (ST-40), zhigou (TB-6), zhaohai (KI-6)
Damp-heat of spleen and stomach (7) clear away heat, resolve damp, activate the stomach, strengthen the spleen zhongwan (CV-12), zusanli (ST-36), tianshu (ST-25), neiguan (PC-6)
Stagnation of liver qi (10) relieve the depressed liver, regulate circulation of qi, promote blood circulation, remove stasis taichong (LV-3), quguan (LV-8), ganshu (BL-18), xuehai (SP-10)
Deficiency of spleen qi and kidney qi (4) invigorate the spleen and replenish qi pishu (BL-20), weishu (BL-21), zhongwan (CV-12), zusanli (ST-36)
Deficiency of liver and kidney yin (6) nourish liver and kidney taichong (LV-3), taixi (KI-3), shenshu (BL-23), guanyuan (CV-4)
Deficiency of spleen yang (6) warm and invigorate the spleen and kidney mingmen (GV-4), guanyuan (CV-4), zusanli (ST-36), yinlingquan (SP-9)
Deficiency of lung qi and spleen qi (5) warm the spleen and nourish the lung to replenish qi feishu (BL-13), pishu (BL-20), taibai (SP-3), taiyuan (LU-9)

The authors concluded that the best results were attained in younger patients and those with milder disease manifestation. In a review article on acupuncture treatment of diabetes (40), Hu Hui, of the Dongzhimen Hospital of the Beijing TCM University, observed that points are usually selected among back shu points (e.g., the bladder meridian points), front mu points (e.g., the conception vessel points), and limb points (e.g., spleen, stomach, kidney, and liver points). He listed the most commonly used points as: feishu, pishu, shenshu, zusaanli, sanyinjiao, guanyuan, taixi, zhongwan, geshu, yishu, quchi, hegu, shenmen, diji, neiguan, xuangzhong, fuliu, jinjin, yuye, and chengjiang.


In the U.S., it is uncommon for people to receive acupuncture therapy every day, as is the method used in the clinical studies reported in the Chinese medical journals. Instead, one may undertake a course of therapy with acupuncture once or twice per week. Needless to say, the impact of the intermittent treatment is not as great as with daily acupuncture. However, through the combination of the less frequent acupuncture and the daily ingestion of herbs, one might reasonably expect to accomplish results comparable to those reported in China where the majority of patients get some degree of blood sugar normalization and relief of symptoms. Best results are expected for younger individuals and those who have had diabetes for only a few years.

Most acupuncturists in the U.S. have not been called upon to treat many patients with diabetes, mainly because of the misconception that acupuncture is not suitable for that disorder. Nonetheless, acupuncturists are in a position to provide expert treatment because the points to be needled are also used (in various other combinations) for treating other disorders. For example, the acupuncture point zusanli (called Stomach-36; located on the lower leg) is one of the most commonly used points for chronic diseases and is used especially when the disease is obviously affected by dietary factors. All of the acupuncture points listed above have been used in the U.S. and other countries. The needling techniques reported for the diabetes treatments are also essentially the same as used world-wide, without requiring special additional training.


  1. Maoshing Ni, The Yellow Emperor's Classic of Medicine: A New Translation of the Neijing Suwen with Commentary, 1995 Shambhala, Boston, MA.
  2. Hong-Yen Hsu and Su-Yen Wang (translators), Chin Kuei You Lueh, 1983 Oriental Healing Arts Institute, Long Beach, CA.
  3. Hong-Yen Hsu and Peacher WG, Chen's History of Chinese Medical Science, 1978 Oriental Healing Arts Institute, Long Beach, CA.
  4. Xie Zhufan and Huang Xiokai (eds.), Dictionary of Traditional Chinese Medicine, 1984 Commercial Press, Hong Kong.
  5. Hong-Yen Hsu and Chau-Shin Hsu, Commonly Used Chinese Herb Formulas with Illustrations, 1980 rev. ed., Oriental Healing Arts Institute, Long Beach, CA.
  6. Hong-Yen Hsu, Chinese herb therapy for diabetes mellitus, Bulletin of the Oriental Healing Arts Institute 1978; 3(1): 12-17.
  7. Chen DC, et al., Clinical and experimental studies in treating diabetes mellitus by acupuncture, 1994 Journal of Traditional Chinese Medicine; 14(3): 163-166.
  8. Clayman CB (ed.), AMA Encyclopedia of Medicine, 1989 Random House, New York.
  9. Werbach, MR, Nutritional Influences on Illness, 1993 Third Line Press, Tarzana, CA.
  10. Lu He, Chinese System of Food Cures, 1986 Sterling Publishing Co. Inc., New York.
  11. Guo SS, et al., Changes in tongue color and whole blood viscosity in diabetics treated with Yiqi Yangyin Huoxue Fang, Journal of traditional Chinese Medicine 1989; 30(2): 97-98.
  12. Han DW and Xu RL, Progress in the research of blood activation and hemostasis removal, Abstracts of Chinese Medicine 1988; 2(4): 466-483.
  13. Hson-Mou Chang and Paul Pui-Hay But (eds.), Pharmacology and Applications of Chinese Materia Medica, (2 vols.), 1986 World Scientific, Singapore.
  14. Zhu KY, Guo SS, Liang XC, Diabetes mellitus treated by traditional Chinese medicine, Journal of the American College of Traditional Chinese Medicine 1983; 1: 24-30.
  15. Li Yucai, et al., Treatment of 33 cases of diabetic ketonuria with Jiang Tong Tang, New Journal of Traditional Chinese Medicine 1989; 21(2): 20-22.
  16. Huang RL, et al., Studies on the antihyperglycemic actions of Chinese herbs, 1980-1984 The Annual Reports of the National Research Institute of Chinese Medicine, Taipei Hsien, Taiwan.
  17. Wang Qi and Dong Zhi Lin, Modern Clinical Necessities for Traditional Chinese Medicine, 1990 China Ocean Press, Beijing.
  18. Gao JZ, Treatment of diabetes with Shen Qi Tao Hong Tang, Journal of Zhejiang Traditional Chinese Medical College 1989; 13(1): 15-16.
  19. Shang Xianmin, et al., Practical Traditional Chinese Medicine and Pharmacology: Clinical Experiences, 1990 New World Press, Beijing.
  20. Dong Zhi Lin and Jiang Jing Xian, 100 Famous and Effective Prescriptions of Ancient and Modern Times, 1990 China Ocean Press, Beijing.
  21. Zhang Junwen, et al., Integrating Chinese and Western Medicine: A Handbook for Practitioners, 1993 Foreign Languages Press, Beijing.
  22. Chen Song Yu and Li Fei, A Clinical Guide to Chinese Herbs and Formulae, 1993 Churchill Livingstone, London.
  23. Ni YX, et al., Clinical and experimental studies on the treatment of diabetes mellitus with berberine, Journal of Integrated Traditional and Western Medicine 1988; 8(12): 711-713.
  24. Kimura M and Suzuki J, The pharmacological role of ginseng in the blend effect of traditional Chinese medicines in hyperglycemia, 1985 Advances of Chinese Medicinal Materials Research, World Scientific, Singapore.
  25. Chen KJ and Zhang WP, Advances on antiageing herbal medicines in China, Abstracts of Chinese Medicine 1987; 1(2): 309-330.
  26. An GY, et al., Treatment of 102 cases of non-insulin dependent diabetes mellitus with Gan Lu Xiao Ke capsule, Journal of Traditional Chinese Medicine 1985; 26(6): 431-432.
  27. Yao QG, Integrated Chinese and Western treatment of 53 cases of diabetes, Chinese Journal of Integrated Traditional and Western Medicine 1987; 7(6): 363-364.
  28. Li ZZ and Du BR, Treatment of 17 cases of diabetic retinopathy by qi benefiting, yin nourishing, stasis eliminating, and nodule dissolving method, Liaoning Journal of Traditional Chinese Medicine 1991; 18(8): 19-21.
  29. Lin L, et al., A clinical study on treatment of vascular complications of diabetes with the sugar-reducing and pulse-invigorating capsule, Journal of Traditional Chinese Medicine (English) 1994; 14(1): 3-9.
  30. Dong Zhi Lin and Yu Shu Fang, Modern Study and Application of Materia Medica, 1990 China Ocean Press, Beijing.
  31. Zhang JQ and Zhou YP, Research into the use of Chinese herbs which inhibit the mechanism responsible for diabetic ophthalmopathy, International Journal of Oriental Medicine 1992; 17(3): 160-164.
  32. Hu Y, Recent advances on diabetes mellitus in acupuncture and Chinese medicine, Oriental Healing Arts International Bulletin 1988; 13(2): 154-162.
  33. Fegn JH, et al., 103 cases of diabetes mellitus treated by Jiang Tang Le, Journal of the Shangdong College of Traditional Chinese Medicine 1994; 18(6): 376-377.
  34. Andallu B, et al., Effect of mulberry therapy on plasma and erythrocyte membrane lipids in patients with type 2 diabetes, Journal of Clinical Chemistry 2001; 314(1-2): 47-53.
  35. Zhang H and Teng Y, Effect of liren (litchi seed) anti-diabetes pills in 45 cases of diabetes mellitus, Journal of Traditional Chinese Medicine 1986; 6(4): 277-278.
  36. Chen QM and Xie MZ, Studies on the hypoglycemic effect of Coptis chinensis and berberine, Herb Studies Journal 1986; 21(6): 401-406.
  37. Chen DC, Gong, DQ, and Zhai Y, Clinical and experimental studies in treating diabetes mellitus with acupuncture, Journal of Traditional Chinese Medicine 1994; 14(3): 163-166.
  38. Hou AL, Blood sugar response of diabetes to acupuncture of sanyinjiao, International Journal of Clinical Acupuncture, 1993; 4(4): 361-364
  39. Liu ZC and Sun FM, Acupuncture treatment of non-insulin-dependent diabetes mellitus: a clinical study, International Journal of Clinical Acupuncture, 1994; 5(3): 249-259.
  40. Hu H, A review of treatment of diabetes by acupuncture during the past forty years, Journal of Traditional Chinese Medicine, 1995; 15(2): 145-154.
  41. Lu Renhe, Treatment of diabetes in the elderly-an analysis of 885 cases, Journal of Traditional Chinese Medicine, 1993; 13(2): 83-91.
  42. Sarif AP and Joglekar VK, Study of the effect of Karnim in patients with non-insulin dependent diabetes mellitus, Ancient Science of Life 1993 9(4): 221-223.

December 2002

2.1. Herbs in Both TCM and TIM

2.1.1. Gymnema sylvestre Schult (syn. Periploca sylvestris Retz)

Gymnema sylvestre Schult, belonging to genus Gymnema and family of Apocynaceae, grows in the tropical forests of southern and central India, southern China, Vietnam, Australia, and African countries. The leaves of G. sylvestre have been used for treatment of diabetes, hypercholesterolemia, joint pain, and snake bites in India and China [37, 38]. The leaf extract of the G. sylvestre has also been marketed as herbal supplements for diabetic patients [39]. The major chemical components are gymnemic acids I-VII, triterpenoid saponins (gymnemosides A-F and gymnemoside W1-2), conduritol A, and dihydroxy gymnemic triacetate.

The major bioactive constituents are gymnemic acids, a group of oleanane-type triterpenoid saponins including gymnemic acids I-VII, gymnema saponins and their derivatives such as deacylgymnemic acid (DAGA) which is the 3-O-glucuronide of gymnemagenin (3,16,21,22,23,28-hexahydroxy-olean-12-ene) [38].

In alloxan-induced diabetic mice, body weight as well as pancreas and liver weight were increased by oral administration of the leaf or callus extract of G. sylvestre at a dose of 200 mg/kg [39]. The effect of the extracts was similar to 4 unit/kg of insulin. Hepatic glycogen levels were also increased (2.15 to 2.47 mg/g versus 1.35 mg/g for the extracts and control, respectively), which in turn could stimulate the secretion of insulin. In streptozotocin (STZ)-induced DM rats, the hexane, acetone, and methanol extracts decreased plasma glucose levels. The acetone extract was found to be most potent. Oral administration of 600 mg/kg of the acetone extract for 45 days decreased the glucose level from 443 to 114 mg/L. Dihydroxy gymnemic triacetate was identified to be the major active component; at 5–20 mg/kg, it showed significant effects on lowering blood glucose level by increasing plasma insulin levels. G. sylvestre extracts were shown to be able to regenerate pancreatic β cells and increase circulating insulin level by stimulating its secretion [40].

In one small clinical study, the fasting blood glucose (FBG) and HbA1C levels were improved in T2DM patients after receiving 200 mg of ethanolic extract of G. sylvestre either daily or their usual treatment for 18 to 20 months [41]. In a second clinical trial, the subjects showed reduced polyphagia, fatigue, blood glucose (fasting and postprandial), and HbA1C in comparison to the control group following an oral dose of 500 mg of herbal extract for a period of 3 months [42]. In an uncontrolled trial involving 65 patients with T1DM and T2DM, the FBG and HbA1C levels were decreased 11% and 0.6%, respectively, after oral dose of 800 mg daily of G. sylvestre extract [41].

2.1.2. Momordica charantia

Momordica charantia, a tendril-bearing vine belonging to the Cucurbitaceae family (also known as bitter melon/gourd, karela, or balsam pear), is a popular plant used for the treatment of diabetes in China, South America, India, the Caribbean, and East Africa [32, 43].

In M. charantia seeds, the major components have been identified to be eleostearic acid and stearic acid, which account for approximately 45% of total weight. Several glycosides, such as charantin and vicine, were isolated from the M. charantia stem and fruit. Other components include polypeptide-p, lipids, triterpenoids, and alkaloids [43].

The methanol extract of M. charantia exhibited hypoglycemic effects in diabetic male ddY mice at a dose of 400 mg/kg. M. charantia can also suppress glucose tolerance and postprandial hyperglycaemia in rats [43] by inhibiting the absorption of carbohydrates from the gastrointestinal tract.

Leung et al. reviewed clinical trials examining the hypoglycemic effects with M. charantia in T2DM patients. However, contradictory clinical outcomes were observed among these trials, probably due to poor methodological design without baseline characterizations along with non-standardized extraction method [43]. Nevertheless, the M. Charantia juice from the fresh fruit showed glucose-lowering effects in T2DM patients [44, 45], but not the extract from the dried fruit [46].

The extract of M. charantia using ethyl acetate was able to activate peroxisome proliferator-activated receptors (PPARα and γ) and upregulate the expression of the acyl CoA oxidase gene in H4IIEC3 hepatoma cells. The suppression of peroxidation and apoptosis resulted in improvements in β-cell function and enhanced insulin excretion. In adipocytes, the momordicosides from M. charantia stimulated glucose transporter-4 (GLUT4) translocation to the cell membrane and increased the activity of adenosine monophosphate-activated protein kinase (AMPK), which could enhance glucose uptake from the blood. Animal studies showed that the extract could also enhance insulin sensitivity and lipolysis. In STZ rats, gluconeogenesis was inhibited by M. charantia via downregulation of hepatic glucose-6-phosphatase (G6P) and fructose-1,6-bisphosphatase activities [47].

2.1.3. Morus alba L

The mulberry tree (Morus alba L.) grows widely in Asian countries, and various substituents of its leaves, Folium mori, have been applied clinically in TCM [48] as hypoglycemic, hypotensive, and diuretic agents. Folium mori have been traditionally used to treat hyperglycemia. The main bioactive components are flavonoids, alkaloids (1-deoxynojirimycin), and polysaccharides [33].

In T2DM mice (high sucrose-fed KK-Ay mice), Folium mori extract reduced insulin resistance following 8-week treatment. Both FBG levels and urinary glucose levels were significantly lowered in mice fed with a diet supplemented with Folium mori extract in a dose-dependent manner [49]. In Goto-Kakizaki rats, a spontaneous nonobese animal model for T2DM, the Folium mori extract demonstrated reduced postprandial blood glucose levels [50]. In human subjects, it showed that a food-grade mulberry powder enriched 1-deoxynojirimycin suppressed postprandial blood glucose serge [50, 51].

In vitro cell studies showed that in adipocytes, Folium mori extract increased glucose uptake and thus enhanced the translocation of GLUT-4 with concentrations ranging from 5 to 45 mcg/mL [52, 53]. In db/db mice, the extract ameliorated adipocytokines in white adipose tissue possibly due to the inhibition of oxidative stress [52]. One of the alkaloids, 1-deoxynorimycin, is also a potent inhibitor of α-glucosidase [54].

2.1.4. Trigonella foenum-graecum L

The fenugreek is an annual plant in the family Fabaceae. The fenugreek seed was a traditional remedy used by ancient Egyptians and spread to Asian countries such as China and India [55]. Fenugreek seeds are a rich source of the polysaccharide galactomannan and also contain saponins such as diosgenin, yamogenin, gitogenin, tigogenin, and neotigogens. Other active constituents include mucilage, volatile oils, and alkaloids [56, 57].

The hypoglycemic effects of T. foenum-graecum in rats were firstly reported in 1974 [58]. Soon afterwards, the amino acid 2S,3R,4S, 4-hydroxyisoleucine, purified from fenugreek seeds, showed insulinotropic effects which increased peripheral glucose uptake in vitro [59–61]. The activities of hepatic enzymes hexokinase, glucokinase, G6P, and fructose-1,6-bisphosphatase were reduced in DM rats [62, 63]. Plasma glucose levels decreased after receiving the T. foenum-graecum extract in both non-DM patients and DM patients [64, 65]. Insulin levels were significantly higher in the fenugreek treatment group in comparison to the placebo treatment [66]. A meta-analysis of T. foenum-graecum showed that the herb may reduce HbA1C by 1.13%  (P = 0.03) [67].

2.2. Other Herbs in TCM

2.2.1. Radix rehmanniae

Radix rehmanniae is the root of Rehmannia glutinosa Libosch, under the family of Scrophulariaceae or Gesneriaceae. It has been widely used for treatment of diseases relating to blood, immune, endocrine, nervous, and cardiovascular systems.

The bioactive components of Radix rehmanniae include catalpol, rehmannioside A, B, C, and D, phenethyl alcohol derivatives such as leucosceptoside A and purpureaside C, monocyclic sesquiterpenes as well as their glycosides [68].

Radix Rehmanniae showed hypoglycemic activity in normal and STZ-induced DM mice. In Chinese medicine, it is usually prepared in combination with other herbs such as Radix ginseng, Radix scutellariae [69], and Radix astragali [70]. These combinations stimulated insulin secretion and β-cell proliferation through insulin receptor substrate 2 induction. It also showed improvements in diabetic foot ulcer healing in rats through the processes of tissue regeneration, angiogenesis, and inflammation control [70]. The postulated mechanisms of action are stimulation of insulin secretion, regulation of glucose metabolism in DM rats, and reduction of hepatic glycogen content of non-DM mice [31, 71].

2.2.2. Stephania tetrandra Moore

Stephania tetrandra Moore is an herbaceous perennial vine of the Menispermaceae family, which is a fundamental herb used in TCM for the reduction of swelling and also providing an analgesic effect. The root of S. tetrandra has demonstrated to have anti-inflammatory, anti-allergic and hypotensive effects in experimental animal studies [72].

The major components are alkaloids, including tetrandrine, fangchinoline, bisbenzylisoquinoline, protoberberine, morphinane, and phenanthrene [73]. At 0.3–3 mg/kg, fangchinoline significantly decreased blood glucose and increased blood insulin in STZ-mice by potentiating insulin release [31]. In another study, formononetin, one of the active components in Radix astragali, potentiated the effect of S. tetrandra on lowering the blood glucose level and increasing the blood insulin level, although no direct anti-hyperglycemic effect of formononetin was observed [72]. The postulated antidiabetic mechanism of S. tetrandra extract is the stimulation of insulin release in pancreatic β-cells [72, 74].

2.2.3. Rhizoma coptidis

Rhizoma coptidis is the rhizome of Coptis chinensis Franch that belongs to the Ranunculaceae family, recorded as Coptidis Rhizoma (CR) in the Chinese Pharmacopeia with the Chinese name of Huang Lian. It has been widely used to clear heat, dry dampness, and eliminate toxins from the body. It is also a commonly used herb in various formulas against intestinal infections, diarrhea, inflammation, hypertension, and hypoglycemia.

The most well-known components of Rhizoma coptidis are isoquinoline alkaloid and berberine [75] which has variety of biological activities such as tumor reduction, anti-microbial, anti-Alzheimer's disease, anti-hyperglycemic, anti-inflammatory, and anti-malarial [76]. The berberine compounds of Rhizoma coptidis have been studied for its anti-hyperglycemic effects. The other alkaloids include palmatine, jateorrhizine, epiberberine, and coptisine.

Both the extract and pure berberine significantly decreased blood glucose and serum cholesterol levels in high fat diet-fed mice at the dose of 200 mg/kg by gavage. In alloxan-induced diabetic mice, berberine showed an anti-hyperglycemic effect and also blunted blood glucose increase induced by intraperitoneal glucose or adrenaline administration in normal mice. The activity of berberine was similar to sulfonylureas or biguanides [31, 77].

The anti-hyperglycemic effects of berberine could be due to the improvement of insulin sensitivity by activating the AMPK pathway or inducing insulin receptor expression. Berberine could also improve fatty acid oxidation via activation of AMPK and acetyl-CoA carboxylase. Furthermore, six quaternary protoberberine-type alkaloids of berberine inhibited aldose reductase activity in vitro with an IC50 less than 200 μM [77, 78]. However, no evidence from in vivo studies is available to verify this mechanism.

2.2.4. Radix astragali

Radix astragali, Chinese name of Huang Qi, is the dried root of perennial herbs Astragalus membranaceus (Fisch.) Bunge and Astragalus mongholicus (Fabaceae) Bunge of the Leguminosae family and grows in northern China. The major active compounds in Radix astragali are isoflavones and isoflavonoids (formononetin, calycosin, and ononin), saponins (astragaloside IV, astragaloside II, astragaloside I and acetylastragaloside), and astragalus polysaccharides [79].

Radix astragali possesses a broad spectrum of effects such as immunostimulation, hepatoprotection, diuresis, analgesia, expectorant, and sedation. In traditional Chinese medicinal theory, the herb is capable of consolidating the exterior of the body and can alleviate heat in the muscles by ascending positive qi [70, 80].

After treating DM Sprague-Dawley rats with Radix astragali decoction (500 mg/kg IP daily) for two months, improvements in insulin sensitivity and attenuation of fatty liver development were observed. However, blood glucose levels, β-cell function, and glucose tolerance were not substantially improved. Radix astragali polysaccharides reduced hyperglycemia and led to indirect preservation of β-cell function and mass via immunomodulatory effects in T1DM mice. In addition, its polysaccharides restored glucose homeostasis in T2DM mice/rats by increasing insulin sensitization. Formononetin, calycosin and ononin might exert a synergistic hypoglycemic effect with fangchinoline in STZ-diabetic mice, most likely by increasing insulin release [70, 80].

2.2.5. Eriobotrya japonica Lindl

The loquat Eriobotrya japonica Lindl., a fruit tree in the family Rosaceae, is indigenous to central and south China. The dried leaves of E. japonica, also called Folium eriobotryae, have been used for treatment of chronic bronchitis, cough, and diabetes. The active compounds in E. japonica are identified to be triterpenes, sesquiterpenes, flavonoids, megastigmane glycosides and polyphenolic compounds including ursolic acid, oleanolic acid, cinchonain Ib, procyanidin B-2, chlorogenic acid, and epicatechin [81–83].

In an in vitro study using insulin receptor substrate-1 cells, the aqueous extract and the cinchonain Ib (one of the components in E. japonica) enhanced insulin secretion in a dose-dependent manner [84]. In vivo studies showed that the aqueous extract of E. japonica could transiently reduce blood glucose levels [84]. The 70% ethanol extract exerted a significant hypoglycemic effect on alloxan-diabetic mice following oral doses of 15, 30, and 60 g/kg (crude drug). The total sesquiterpenes were found to significantly lower blood glucose levels in both normal and alloxan-diabetic mice [85]. Shih et al. found that the extract, with major components of tormentic acid, maslinic acid, corosolic acid, oleanolic acid, and ursolic acid, could ameliorate high fat induced hyperglycemia, hyperleptinemia, hyperinsulinemia and hypertriglyceridemia [86]. Another study found that the co-fermentation of Folium eriobotryae and green tea leaf reduced the blood glucose level by 23.8% within 30 min in maltose-loaded SD rats at a dose of 50 mg/kg, although this effect was not observed in the sucrose- and glucose-loaded rats [87].

2.2.6. Ginkgo biloba

The Ginkgo biloba tree, native to China, dates back to the prehistoric ages of 250–300 million years and is frequently called a “living fossil” [88]. Today, the biloba tree can live more than 1,000 years [89]. In the United States, G. biloba is one of the most frequently used over-the-counter (OTC) herbal supplements [90]. Extract from its leaves contains ginkgo flavonoid glycosides, terpene lactones, and ginkgolic acids. Many human clinical trials have examined possible ginkgo uses in cerebrovascular disease, tinnitus, sexual dysfunction, intermittent claudication, migraine prophylaxis, and alleviating symptoms of the common cold [15, 91–94]. However, the most common use of ginkgo is the prevention and treatment of Alzheimer's disease and dementia [95–100].

The administration of the ginkgo extract, EGb 761, in rats with DM increased glucose uptake into hepatic and muscle tissues [101] and decreased atherogenesis, a common comorbidity of DM [102]. In vitro assays determined the possible anti-diabetic effect of ginkgo to be through the inhibition of α-glucosidase and amylase activities [103]. Clinical investigations of the anti-diabetic properties of ginkgo in humans have produced mixed results. Healthy human subjects showed no reduction in blood glucose levels with an accompanying significant increase in plasma insulin levels [104]. The randomized double-blinded clinical study involving non-DM, pre-T2DM, and T2DM patients showed that ginkgo did not increase insulin sensitivity nor reduced blood glucose levels [105, 106]. However, in T2DM patients, ingestion of G. biloba extract showed increased clearance of insulin, resulting in a reduction plasma insulin levels and elevated blood glucose. Gingko may improve endothelial function in T2DM patients with early stages of nephropathy, but without affecting blood glucose levels [107]. While popular for its many possible indications, gingko appears to have limited anti-diabetic properties to warrant its use in diabetes.

2.2.7. Radix ginseng

Radix ginseng is native in the northern hemisphere, most notably, in eastern Asia (northern China, Korea, and eastern Siberia) and northern America. Subsequently, ginseng is often named from its origin—Asian ginseng, American ginseng, Chinese ginseng, to name a few. More than 700 compounds have been identified in ginseng, with the most active components being identified as the ginsenosides (Rb1, Re, Rd), polysaccharides, peptides, and polyacetylenic alcohols [108]. The geographical origin of ginseng, in combination with the extraction and processing method, produces variable anti-diabetic results [32, 108, 109].

The anti-diabetic activity of Ridix ginseng has been explored in both animal and human studies. Hypoglycemic activity is greater in lipophilic extracts than aqueous extracts. In DM rats, Korean ginseng (0.1–1.0 g/mL) stimulated the release of insulin from isolated pancreatic islets. American ginseng (100 mg/kg) produced lowered levels of serum glucose and HbA1C in DM rats [110]. Vuksan and colleagues have conducted a number of human clinical trials demonstrating that ginseng reduced postprandial blood glucose, fasting blood glucose, and HbA1C levels [111–115]. Similar results were presented at American Diabetes Association Annual Meeting in 2003 [116].

Pharmacologically, ginseng has antioxidant properties. It also reduces β-cell apoptosis by upregulating adipocytic PPAR-γ protein expression [117]. Ginseng impairs glucose absorption by decreasing glucosidase activity [118]. It may also increase insulin sensitivity in peripheral tissues [32]. One of the active components, ginsenoside Rb1, can enhance glucose transport by inducing the differentiation of adipocytes via upregulating the expression of PPAR-γ and C/EBP-α [119]. In addition, ginsenoside Rb1 can increase GLUT-4 activity leading to increased uptake of glucose from blood by adipocytes [120].

2.2.8. Fructus schisandrae

Fructus schisandrae (also known as “five-flavor berry” in China), the fruit of a deciduous woody vine native to forests of northern China, is traditionally used as a tonic or sedative agent. It has been used in TCM to astringe the lungs and nourish the kidneys. It was reported that Fructus schisandrae can enhance hepatic glycogen accumulation and decrease hepatic triglycerides. It has also been used in various TCM formulas, such as the modified Ok-Chun-San and modified Huang-Lian-Jie-Du-Tang, to treat diabetes [121]. The major chemical components include lignans such as schizandrins (schizandrin A) and gomisins (gomisin A, J, N, and angeloylgomisin H), and polysaccharides [72],

In vitro, gomisin J, gomisin N and schizandrin A increased basal glucose uptake in HepG2 cells [122]. Several other schizandrins were found to be able to prevent β-cell apoptosis and decrease insulin resistance [123]. In an in vitro study using 3T3-L1 adipocytes, several fractions of ethanol extract showed the stimulation effect of PPAR-γ. Among these fractions, FS-60, a subfraction from the 70% ethanol extract, was identified to be most potent with the major components of schizandrin A, gomisin A, and angeloylgomisin H. In an in vivo study using pancreatectomized DM rats, FS-60 lowered serum glucose levels during the OGTT similar to the level of the fasting stage. During hyperglycemic clamp, FS-60 increased the first phase insulin secretion in diabetic animals [121].

The major mechanisms are hypothesized to be the stimulation of insulin secretion and increased insulin sensitivity by ameliorating insulin resistance via increased PPAR-γ activity. Fructus schisandrae can also improve glucose homeostasis in DM mice by inhibiting aldose reductase [121].

2.2.9. Pueraria lobata (Gegen)

Gegen is the dried root of Pueraria lobata (Willd.) Ohwi, a semiwoody, perennial and leguminous vine native to South east Asia, and also known as yegen, kudzu root, and kudzu vine root [124, 125]. For more than 2000 years, gegen has been used as an herbal medicine for the treatment of fever, acute dysentery, diarrhea, DM, and cardiovascular diseases [126, 127]. Over seventy compounds have been identified in gegen, with isoflavonoids (puerarin) and triterpenoids being the major constituents.

In vitro studies showed that puerarin contained in P. lobata can enhance the glucose uptake in a dose-dependent manner performed in high glucose-treated preadipocytes [128]. Puerarin also promoted insulin-induced preadipocyte differentiation and upregulated mRNA expression of PPARγ, which can regulate glucose homeostasis, adipocyte differentiation, and lipid metabolism [129]. In China, a clinical trial was conducted in DM patients using the Gegen Qin Lian decoction which showed a dose-dependent effect on reducing HbA1C and FBG [130]. Possible mechanisms of action from in vitro and in vivo studies include α-glucosidase inhibition, increased expression and activity of PPAR-γ, upregulation of GLUT-4 mRNA, increased plasma endorphins, and preservation of pancreatic islets [131–133].

2.2.10. Cornus officinalis Sieb. et Zucc

Cornus officinalis Zucc., native to China, Japan, and Korea, is a common herbal medicine of the family of Cornaceae. Fructus corni is the dried ripe sarcocarp of C. officinalis Sieb. et Zucc. Cornaceae, which has been widely prescribed as a tonic agent in Chinese medicinal formula and possess activities of improving the function of the liver and kidney [134]. The major active components are iridoid glycosides, morroniside, loganin, mevaloside, loganic acid, ursolic acid and oleanolic acid, 5-hydroxymethyl-2-furfural, and 7-O-galloyl-D-sedoheptulose [135].

The ethanol extract of Fructus corni induced the expression of GLUT-4 by stimulating the proliferation of pancreatic islets, resulting in increased insulin secretion [136]. One of the active components, ursolic acid, was found to be an inhibitor of protein tyrosine phosphatase (PTP) 1B, which sensitizes the effects of insulin [137]. The Fructus corni extract decreased blood sugar in STZ mice and reduced renal oxidative stress and glycation products in STZ-induced diabetic rats. The underlying mechanisms include the inhibition of glucosidase, reduction of gene expression for hepatic gluconeogenesis, protection of β-cells against toxic challenges, and enhancement of insulin secretion.

2.3. Other Herbs in TIM

2.3.1. Barringtonia racemosa

Barringtonia racemosa is an evergreen mangrove tree that grows in Bangladesh, Sri Lanka, and the west coast of India, with the bark and leaves used for snake bites, rat poisoning, boils, and gastric ulcers. The extracts from different parts have various biological activities including anti-cancer, analgesic, anti-DM, anti-bacterial, and anti-fungal activities. Its seeds are aromatic and useful in colic and ophthalmic disorders [138].

Several diterpenoids and triterpenoids have been identified in B. racemosa extract and a pentacyclic triterpenoid, bartogenic acid, is the major active component [138, 139]. The hexane, ethanol and methanol extracts as well as the pure compound of bartogenic acid inhibited intestinal α-glucosidase activity at concentrations ranging from 0.02–0.2 μg/mL in an in vitro enzymatic study. In an in vivo rat study, the methanol extract was found to suppress the rise of blood glucose level after receiving maltose [140].

2.3.2. Syzygium cumini (L.) Skeels

Syzygium cumini (L.) Skeels, frequently referred to as Skeels, is a tropical tree native to India, China, and Indonesia. Skeels is also known as Eugenia jambolana, Jamun, Jambu, Black Plum, or Black Berry and has been frequently used to treat DM in India [140] and Brazil [141]. Studies using DM rats showed reductions in blood glucose, post prandial glucose, cholesterol, and free fatty acid [142, 143]. Pharmacologically, the extracts of S. cumini have shown α-glucosidase inhibitory activities [144, 145]. Hepatic enzymatic activities of glucokinase and phosphofructokinase, hepatic enzymes which play a role in glucose metabolism, were significantly reduced in DM animals [145, 146]. Adenosine deaminase activity was inhibited in Skeels-treated erythrocytes procured from both DM and non-DM patients. However, clinical trials have not produced favorable results. Two double-blind, randomized trials involving non-DM and DM patients did not support the use of Skeels in DM [147, 148]. In patients with DM consumed tea prepared from S. cumini leaves, FBG levels were not reduced significantly.

2.3.3. Tinospora cordifolia

Tinospora cordifolia, also called Guduchi of the Menispermaceae family, is a succulent climbing shrub, indigenous to the tropical areas of India, Myanmar, and Sri Lanka. The aqueous stem extract is used for curing gastrointestinal pain [149]. T. cordifolia also has anti-spasmodic, anti-pyretic, anti-allergic, anti-inflammatory, immunmodulatory, and anti-leprosy activities [150]. The bioactive ingredients are alkaloids (palmatine, jatrorrhizine and magnoflorine), diterpenoid lactones, glycosides, steroids, sesquiterpenoid, phenolics, aliphatic compounds, and polysaccharides.

The anti-DM activity of T. cordifolia has been investigated in DM mice. The aqueous and alcoholic extract of the plant can improve glucose tolerance in DM rats. Grover and coworkers found that T. cordifolia ameliorated diabetic neuropathy at a dose of 400 mg/kg [151]. The 70% ethanol extract significantly decreased blood glucose levels and attenuated the rate of blood glucose elevation after 2 g/kg glucose loading following an oral dose of 100 or 200 mg/kg of T. cordifolia for 14 days [152]. The extract was also found to be able to prevent diabetic retinopathy in STZ diabetic rats at a dose of 250 mg/kg [153].

The anti-DM effect is related to the amelioration of oxidative stress by reducing the production of thiobarbituric acid-reactive substances. The extract can increase the expression of thioredoxin and glutaredoxin. T. cordifolia extract can also adjust alter carbohydrate metabolism and reduce gluconeogenesis via inhibiting G6P and fructose 1,6-diphosphatase [154]. Other possible mechanisms examined are the enhancement of the insulin release and inhibition of α-glucosidase [155].

2.3.4. Ocimum basilicum

Ocimum basilicum, with the common name of basil, or sweet basil, is a culinary herb of the family Lamiaceae (mints), which is sometimes known as Saint Joseph's Wort. Basil was originally from India and widely used in Southern Asian.

Basil is a potent anti-septic and preservative agent and also demonstrates slight sedative effects, regulation of digestion, and diuresis. Clinically, it has been used to treat headache, cough, upper respiratory tract infection, and kidney dysfunction. Laboratory studies have found that basil also has activities in lowering blood sugar, stimulating nervous system, and protection from radiation [156, 157].

The major components of basil consist of apigenin, linalool, and ursolic acid, which previously demonstrated anti-viral activity [158]. Basil improved lipid metabolism in hypercholesterolemic rats [159]. In an in vitro cell line study using human macrophages, the ethanol extract of basil reduced cholesterol synthesis [160]. The aqueous extract of O. basilicum can inhibit rat intestinal sucrase, maltase, and porcine pancreatic α-amylase activities which may have positive effect for treatment of DM [161]. In a clinical trial in DM patients in India, the basil leaf extract decreased the fasting blood glucose by 21.0 mg/dL, and postprandial blood glucose fell by 15.8 mg/dL. The results suggest that O. basilicum may be used as a dietary therapy in mild to moderate T2DM [162].

2.3.5. Berberis aristata

Berberis aristata (also known as Zarshik, Daruharidra) of the family Berberidaceae is an Ayurvedic herb which has been used since ancient times in South Asia as an herbal tonic agent to improve hepatic and cardiac functions [163, 164].

The main constituents of the root have been identified as berberine, berbamine and palmatine [165]. The extract of B. aristata (root) has a strong potential to regulate glucose homeostasis by decreasing gluconeogenesis and oxidative stress. In DM rats, the extract increased the glucokinase and G6P dehydrogenase activities but decreased G6P activity [165]. In patients with sub-optimal glycemic control, HbA1C, basal insulin, insulin resistance, total and low-density lipoprotein cholesterol, and triglycerides were significantly reduced after 90-day treatment with combination of B. aristata extract and Silybum marianum extract [166].


Leave a Reply

Your email address will not be published. Required fields are marked *